Cargando…
CoViTris2020 and ChloViD2020: a striking new hope in COVID-19 therapy
ABSTRACT: Designing anticoronavirus disease 2019 (anti-COVID-19) agents is the primary concern of medicinal chemists/drug designers nowadays. Repurposing of known active compounds against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a new effective and time-saving trend in ant...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778709/ https://www.ncbi.nlm.nih.gov/pubmed/33389560 http://dx.doi.org/10.1007/s11030-020-10169-0 |